These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9789 related articles for article (PubMed ID: 1480041)

  • 1. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
    Stetler-Stevenson WG; Krutzsch HC; Liotta LA
    Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
    Stetler-Stevenson WG; Krutzsch HC; Liotta LA
    J Biol Chem; 1989 Oct; 264(29):17374-8. PubMed ID: 2793861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
    Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
    Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
    [No Abstract]   [Full Text] [Related]  

  • 4. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ; Howard EW; Herron GS; Apodaca G
    Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1.
    Agrez MV; Meldrum CJ; Sim AT; Aebersold RH; Clark IM; Cawston TE; Burns GF
    Biochem Biophys Res Commun; 1995 Jan; 206(2):590-600. PubMed ID: 7826376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
    Ward RV; Hembry RM; Reynolds JJ; Murphy G
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
    Moll UM; Youngleib GL; Rosinski KB; Quigley JP
    Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent collagenase and gelatinase from human neutrophils and their activation.
    Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
    Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
    Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
    J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
    Li L; Akers K; Eisen AZ; Seltzer JL
    Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity.
    Walther SE; Denhardt DT
    Cell Growth Differ; 1996 Nov; 7(11):1579-88. PubMed ID: 8930408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts.
    Aimes RT; Li LH; Weaver B; Hawkes S; Hahn-Dantona EA; Quigley JP
    J Cell Physiol; 1998 Mar; 174(3):342-52. PubMed ID: 9462696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 490.